"Hemostatics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.
Below are MeSH descriptors whose meaning is more general than "Hemostatics".
Below are MeSH descriptors whose meaning is more specific than "Hemostatics".
This graph shows the total number of publications written about "Hemostatics" by people in Harvard Catalyst Profiles by year, and whether "Hemostatics" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 1 | 2 |
| 1998 | 3 | 0 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 2 | 3 |
| 2001 | 4 | 3 | 7 |
| 2002 | 1 | 3 | 4 |
| 2003 | 3 | 1 | 4 |
| 2004 | 2 | 0 | 2 |
| 2005 | 3 | 0 | 3 |
| 2006 | 6 | 1 | 7 |
| 2007 | 3 | 1 | 4 |
| 2008 | 7 | 1 | 8 |
| 2009 | 8 | 0 | 8 |
| 2010 | 4 | 1 | 5 |
| 2011 | 5 | 3 | 8 |
| 2012 | 4 | 1 | 5 |
| 2013 | 6 | 4 | 10 |
| 2014 | 5 | 3 | 8 |
| 2015 | 10 | 0 | 10 |
| 2016 | 3 | 3 | 6 |
| 2017 | 2 | 1 | 3 |
| 2018 | 5 | 2 | 7 |
| 2019 | 1 | 1 | 2 |
| 2020 | 6 | 1 | 7 |
| 2021 | 11 | 0 | 11 |
| 2022 | 13 | 0 | 13 |
| 2023 | 10 | 0 | 10 |
| 2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Hemostatics" by people in Profiles.
-
Levels of procoagulant factors and peak thrombin generation in relation to dementia risk in older adults: The Cardiovascular Health Study. Thromb Res. 2024 Mar; 235:148-154.
-
Perioperative hemostasis management in patients with von Willebrand disease: an institutional experience. Blood Coagul Fibrinolysis. 2024 Mar 01; 35(2):49-55.
-
Tranexamic Acid for Bleeding Management in Adult Patients on Extracorporeal Membrane Oxygenation. ASAIO J. 2023 12 01; 69(12):e474-e481.
-
Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa. J Thromb Haemost. 2023 12; 21(12):3508-3510.
-
Hemostatic considerations for gender affirming care. Thromb Res. 2023 10; 230:126-132.
-
The role of viscoelastic hemostatic assays for postpartum hemorrhage management and bedside intrapartum care. Am J Obstet Gynecol. 2024 Mar; 230(3S):S1089-S1106.
-
Hemostatic and Immunologic Effects of Platelet Transfusions in Neonates. Clin Perinatol. 2023 12; 50(4):793-803.
-
Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial. Stroke. 2023 09; 54(9):2223-2234.
-
Shear-Mediated Platelet Microparticles Demonstrate Phenotypic Heterogeneity as to Morphology, Receptor Distribution, and Hemostatic Function. Int J Mol Sci. 2023 Apr 17; 24(8).
-
Self-propelling thrombin powder enables hemostasis with no observable recurrent bleeding or thrombosis over 3 days in a porcine model of upper GI bleeding. Gastrointest Endosc. 2023 08; 98(2):245-248.